AME
68
11
GT
30
-6
APA
48
-4
HUM
41
7
WMB
60
-2
CB
51
-2
JBHT
39
-13
EOG
32
-4
PCG
54
-5
PYPL
72
2
PRU
54
-5
HIG
60
-6
ALLE
37
-4
WFC
74
-3
EA
49
2
GPC
44
-3
FCX
43
3
AFL
39
-3
AAP
39
-2
AIV
39
2
AME
68
11
GT
30
-6
APA
48
-4
HUM
41
7
WMB
60
-2
CB
51
-2
JBHT
39
-13
EOG
32
-4
PCG
54
-5
PYPL
72
2
PRU
54
-5
HIG
60
-6
ALLE
37
-4
WFC
74
-3
EA
49
2
GPC
44
-3
FCX
43
3
AFL
39
-3
AAP
39
-2
AIV
39
2
Financhill
Back

The Vita Coco 10K Form

Buy
55

COCO
The Vita Coco

Last Price:
$34.10
Seasonality Move:
6.74%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive COCO News And Ratings

See the #1 stock for the next 7 days that we like better than COCO

COCO Financial Statistics

Sales & Book Value

Annual Sales: $516M
Cash Flow: $-10.4M
Price / Cash Flow: 64.54
Annual Sales: $4.87
Price / Book: 7.07

Profitability

EPS (TTM): 1.01000
Net Income (TTM): $60.6M
Gross Margin: $198.8M
Return on Equity: 24.62%
Return on Assets: 17.7%

The Vita Coco Earnings Forecast

Key The Vita Coco Financial Ratios

  • The Gross Profit Margin over the past 16 years for COCO is 38.52%.
  • The Selling, General & Administrative Expenses for COCO have been equal to 24.22% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of COCO is 10.84% of Total Revenues.
  • Per Share Earnings over the last 16 years have been positive in 9 years.

The Vita Coco Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Beverages
Sector: Consumer Staples
Current Symbol: COCO
CUSIP: 218868
Website: vitacoco.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.76
Quick Ratio: 2.47

Price-to-Earnings

Trailing P/E Ratio: 36.82
Forward P/E Ratio: 24.59

COCO Technical Analysis vs Fundamental Analysis

Buy
55
The Vita Coco (COCO) is a Buy

Is The Vita Coco a Buy or a Sell?

  • The Vita Coco stock is rated a Buy
    The current The Vita Coco [COCO] share price is $34.61. The Score for COCO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.